Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-42,002
Closed -$2.75M 171
2014
Q4
$2.75M Buy
42,002
+661
+2% +$46K 0.71% 60
2014
Q3
$3.15M Buy
41,341
+410
+1% +$33.9K 0.82% 54
2014
Q2
$3.37M Sell
40,931
-3,418
-8% -$255K 0.88% 52
2014
Q1
$3.11M Buy
44,349
+4,077
+10% +$280K 0.87% 51
2013
Q4
$2.89M Buy
40,272
+4,328
+12% +$315K 0.86% 51
2013
Q3
$2.53M Buy
35,944
+1,454
+4% +$97.3K 0.86% 49
2013
Q2
$2.14M Buy
+34,490
New +$2.13M 0.78% 53

Other funds holding NOV

Grimes & Company's NOV Position: Q1 2015 in Review

Grimes & Company sold out of NOV (NOV) in Q1 2015, closing a stake of 42,002 shares — an estimated $2.75M sold.

Grimes & Company first reported a position in NOV in Q2 2013 and held it in 7 quarters. The position peaked at $3.37M in Q2 2014. 826 funds tracked by Wall St. Rank hold NOV as of Q1 2015.

  • Grimes & Company reported no remaining NOV position as of Q1 2015 after selling out during the quarter.
  • Grimes & Company sold 42,002 NOV shares in Q1 2015, an estimated $2.75M.
  • Grimes & Company first reported a position in NOV in Q2 2013 and held it in 7 quarters.
  • Grimes & Company's NOV position peaked at $3.37M in Q2 2014.
  • 826 funds tracked by Wall St. Rank held NOV as of Q1 2015.

Based on Grimes & Company's 13F filing for Q1 2015, filed 24 Apr 2015.